Rising number of surgical processes coupled with increasing trauma cases, increase in road accidents and need for reduction of blood loss coupled with rapid development and launch of innovative tissue sealing compounds are key factors contributing to high CAGR of Hemostasis and Tissue Sealing Agents during forecast period.

According to the current analysis of Reports and Data, the global Hemostasis and Tissue Sealing Agents market was valued at USD 6,421.1 Million in 2020 and is expected to reach USD 12.23 Billion by the year 2028, at a CAGR of 8.30%. Blood loss has always been a concern in surgery. Hemostasis is the formation of blood clots at the site of injury. It is a complex interaction between the platelets plasma proteins and coagulation and fibrinolysis pathways. Platelets provide the initial hemostasis response.

 The number of hemostatic agents and tissue sealants have been developed and are currently used in various surgical disciplines all across the world. Hemostasis and tissue sealing agents are used in medical applications and act as a catalyst in blood clotting. This reduces the time required for clotting of the blood and prevents blood loss. An increase in the adoption of advanced technologies and increasing investment in the healthcare infrastructure is expected to drive the market growth in the coming decades. Additionally, the increasing number of diabetic patients, cardiovascular conditions, urological issues, liver problems, and gastrointestinal conditions owing to the changed lifestyle and inappropriate eating habits among the population is expected to raise the number of surgeries. For instance, according to the CDC, these procedures categories made up 72% of procedures performed on females and 67% of those performed on males. It is anticipated to drive the market growth positively for hemostasis and tissue sealing products in the market during the forecast period.

Key players of the market mentioned in the report are Johnson Johnson, C R Bard, Integra Life Sciences, Cohera Medical, Equimedical, CryoLife, Advance Medical, Solution, Smith Nephew, Pfizer, and B Braun Medical Inc.

Get a sample @ https://www.reportsanddata.com/sample-enquiry-form/2257

The report provides comprehensive assessment of competitive landscape and covers profiling of the key players along with their product portfolios and business strategies. It highlights recent mergers and acquisition, joint ventures, collaborations, partnerships, and product launches and brand promotions among others. The research report is an investigative study providing a conclusive view of the Hemostasis And Tissue Sealing Agents business sphere by an in-depth segmentation of the market into key applications, types, and regions.

Hemostasis And Tissue Sealing Agents Market Segmentation based on Types:

Type (Revenue, USD Million; 2018–2028)

• Topical Hemostats
• Adhesives Tissue sealants
• Others

Material type (Revenue, USD Million; 2018–2028)

• Collagen Based
• Oxidized Regenerated Cellulose (ORC) based
• Gelatin based
• Polysaccharide Based
• Others

Applications Type (Revenue, USD Million; 2018–2028)

• Minimally invasive surgery
• General Surgery
• Others

End Use (Revenue, USD Million; 2018–2028)

• Hospital
• Ambulatory Surgical Centers
• Home Care Settings
• Others

Request a Order on the report @ https://www.reportsanddata.com/report-pricing/2257

Further key findings from the report suggest

• Hemostasis and Tissue Sealing Agents market is growing at a CAGR of 9% in Asia Pacific followed by North America and Europe, with 8.1 % and 8.0 % CAGR, respectively. Increased demand of hemostats and tissue sealants in the surgical processes is driving the growth of the market.
• In 2018, Topical Hemostats segment is expected to dominate Hemostasis and Tissue Sealing Agents which holds 51.3% of the global market. North America regional market is the chief revenue generating source for this product segment, followed by European countries and Asia-Pacific regions
• Chronic diseases like Diabetes, Hernia fixation, urological disorders, spinal injuries, brain hemorrhage and liver injuries are few diseases that require the usage of hemostats and tissue sealing products. Increase in these diseases will ultimately lead to an increase in demand for tissue sealants. For instance, a new 'biological glue' developed by Chinese researchers could one day stop hearts and arteries from uncontrollably bleeding.
• Increased preference of hemostats and tissue sealants over the other products for the process of injury healing or wound closure has led to its increasing use in multiple conditions, especially in endoscopic procedures.
• Minimally invasive surgery is making use of hemostasis and tissue sealing products for urological treatments, thereby promoting the growth of Hemostasis and tissue sealing market. For instance, in June 2019, FDA clears JJ and Grifols' blood-stopping protein spray for surgical bleeds
• The highest demand is expected from the cardiovascular conditions followed by general surgeries. For instance, according to the data of National Center for Health Statistics, 48 million surgical inpatient procedures were performed in the United States
• Owing to the better results obtained by using hemostasis and tissue sealing products in cardiovascular surgeries and general surgeries has attributed to an increased demand for tissue sealing products.
• Topical hemostat is extensively used in general injury treatment and provides cost efficiency, quick and easy absorbability, minimal tissue reaction and non-antigenicity owing to the larger share of the market by topical hemostats segment.
• Hemostasis includes the coagulation of blood vessels, fibrinolysis and platelet aggregation pathways by activation of hemostasis system. Hemostats involve hemostasis agents and their delivering medium which could be ready-to-use applicator or a pre-filled syringe.
• Some of the prime advantages associated with tissue sealants are, ease of use, better visualization, reduced need for transfusion, better application in patients with coagulation disorders, reduced exudates and so on.

To provide an in-depth analysis of the global Hemostasis And Tissue Sealing Agents market with regards to its growth opportunities, production and consumption ratio, supply and demand, and export and import ratio, the market report offers key statistical data across the leading regions of the global Hemostasis And Tissue Sealing Agents market.

Key Regions Covered in the Report:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, France, Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2257

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure your queries are solved and the report is customized to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com